First Light Acquisition Group is a blank check company organized for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization, or other similar business combination with one or more businesses or entities. The company is sponsored by a group of former industry and federal leaders with extensive experience operating public companies and organizations in highly regulated industries, and is led by Thomas Vecchiolla, Chief Executive Officer of FLAG.

Company profile
Ticker
CLDI, FLAG, CLDI-WT
Exchange
Employees
Incorporated
Location
Fiscal year end
Industry (SIC)
AMGEN • Gilead Sciences • Biogen • Qiagen • Moderna • BioNTech SE • Sana Biotechnology • Ginkgo Bioworks • Exelixis • Acorda Therapeutics ...
SEC CIK
Corporate docs
IRS number
862967193
CLDI stock data
Latest filings (excl ownership)
8-K
Entry into a Material Definitive Agreement
18 Sep 23
25-NSE
Exchange delisting
13 Sep 23
8-K
Other Events
11 Sep 23
8-K
Entry into a Material Definitive Agreement
31 Aug 23
8-K
Entry into a Material Definitive Agreement
29 Aug 23
425
Business combination disclosure
24 Aug 23
8-K
Other Events
24 Aug 23
425
Business combination disclosure
22 Aug 23
8-K
Other Events
22 Aug 23
10-Q
2023 Q2
Quarterly report
21 Aug 23
Latest ownership filings
4
William John Weber
14 Sep 23
4
Thomas A. Vecchiolla
14 Sep 23
4
Sander Gerber
14 Sep 23
SC 13G
Funicular Funds, LP
8 Sep 23
SC 13G
METEORA CAPITAL, LLC
8 Sep 23
SC 13D/A
Jackson Investment Group, LLC
28 Jun 23
SC 13G/A
683 Capital Management, LLC
14 Feb 23
SC 13G
First Trust Capital Management L.P.
14 Feb 23
SC 13G/A
Beryl Capital Management LLC
13 Feb 23
SC 13G/A
First Light Acquisition Group, LLC
10 Feb 23
Financial summary
Quarter (USD) | Jun 23 | Mar 23 | Dec 22 | Sep 22 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Dec 22 | Dec 21 | |
---|---|---|---|
Revenue | |||
Cost of revenue | |||
Operating income | |||
Operating margin | |||
Net income | |||
Net profit margin | |||
Cash on hand | |||
Change in cash | |||
Diluted EPS |
Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
---|---|---|---|---|---|---|
Cash on hand (at last report) | 669.87 k | 669.87 k | 669.87 k | 669.87 k | 669.87 k | 669.87 k |
Cash burn (monthly) | (no burn) | (no burn) | 1.40 mm | 844.05 k | (no burn) | (no burn) |
Cash used (since last report) | n/a | n/a | 3.93 mm | 2.38 mm | n/a | n/a |
Cash remaining | n/a | n/a | -3.26 mm | -1.71 mm | n/a | n/a |
Runway (months of cash) | n/a | n/a | -2.3 | -2.0 | n/a | n/a |
Institutional ownership, Q2 2023
13F holders | Current |
---|---|
Total holders | 44 |
Opened positions | 5 |
Closed positions | 7 |
Increased positions | 5 |
Reduced positions | 5 |
13F shares | Current |
---|---|
Total value | 36.78 bn |
Total shares | 12.83 mm |
Total puts | 0.00 |
Total calls | 187.09 k |
Total put/call ratio | – |
Largest owners | Shares | Value |
---|---|---|
Polar Asset Management Partners | 2.58 mm | $4.59 bn |
First Light Acquisition | 2.58 mm | $0.00 |
683 Capital Management | 900.00 k | $3.23 bn |
Finepoint Capital | 655.20 k | $85.18 mm |
Hudson Bay Capital Management | 500.00 k | $5.25 bn |
Aristeia Capital | 494.40 k | $58.96 mm |
NMR Nomura | 467.82 k | $60.82 mm |
Periscope Capital | 409.80 k | $49.43 mm |
Woodline Partners | 400.00 k | $4.20 bn |
Kim | 356.10 k | $3.74 bn |
Recent insider trades
Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
12 Sep 23 | Hudson Bay Capital Management | Class A Common Stock, par value $0.0001 per share | Other | Dispose J | Yes | No | 10.49 | 500,000 | 5.25 mm | 0 |
12 Sep 23 | Thomas A. Vecchiolla | Common Stock, par value $0.0001 per share | Conversion | Acquire C | No | No | 0 | 6,000 | 0.00 | 6,000 |
12 Sep 23 | Thomas A. Vecchiolla | Warrants Common Stock, par value $0.0001 per share | Other | Acquire J | No | No | 11.5 | 66,667 | 766.67 k | 66,667 |
12 Sep 23 | Thomas A. Vecchiolla | Class B Common Stock, par value $0.0001 per share Class A Common Stock, par value $0.0001 per share | Conversion | Dispose C | No | No | 0 | 6,000 | 0.00 | 0 |
12 Sep 23 | Thomas A. Vecchiolla | Class B Common Stock, par value $0.0001 per share Class A Common Stock, par value $0.0001 per share | Other | Acquire J | No | No | 0 | 6,000 | 0.00 | 6,000 |
12 Sep 23 | First Light Acquisition | Common Stock, par value $0.0001 per share | Conversion | Acquire C | Yes | No | 0 | 1,931,852 | 0.00 | 1,931,852 |
12 Sep 23 | First Light Acquisition | Class B Common Stock, par value $0.0001 per share Class A Common Stock, par value $0.0001 per share | Conversion | Dispose C | Yes | No | 0 | 1,931,852 | 0.00 | 0 |
12 Sep 23 | First Light Acquisition | Class B Common Stock, par value $0.0001 per share Class A Common Stock, par value $0.0001 per share | Other | Dispose J | Yes | No | 0 | 166,201 | 0.00 | 1,931,852 |
12 Sep 23 | First Light Acquisition | Class B Common Stock, par value $0.0001 per share Class A Common Stock, par value $0.0001 per share | Sell | Dispose S | Yes | No | 0 | 186,372 | 0.00 | 2,098,053 |
12 Sep 23 | First Light Acquisition | Class B Common Stock, par value $0.0001 per share Class A Common Stock, par value $0.0001 per share | Sell | Dispose S | Yes | No | 0 | 99,388 | 0.00 | 2,284,425 |
News
Why Flux Power Shares Are Trading Lower By 15%? Here Are Other Stocks Moving In Friday's Mid-Day Session
22 Sep 23
Why Gorilla Technology Group Shares Are Trading Lower By 25%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
20 Sep 23
First Light Acquisition Group Announces NYSE Approval For Listing Of Business Combination With Calidi Biotherapeutics And Additional New Capital Commitments
11 Sep 23
Why NIO Are Trading Lower By Over 7%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
29 Aug 23
US Stocks Mostly Flat; Best Buy Posts Upbeat Results
29 Aug 23
Press releases
Calidi Biotherapeutics Debuts as a Publicly Traded Company Focused on Arming the Immune System to Fight Cancer with a New Generation of Targeted Immunotherapies
13 Sep 23
First Light Acquisition Group Announces NYSE Approval for Listing of Business Combination with Calidi Biotherapeutics and Additional New Capital Commitments
11 Sep 23
FIRST LIGHT ACQUISITION GROUP, INC. Further Adjourns Special Meeting of Stockholders to August 28, 2023 at 10:30 am ET
24 Aug 23
FIRST LIGHT ACQUISITION GROUP, INC. Adjourns Special Meeting of Stockholders to August 24, 2023 at 10:30 am ET
22 Aug 23
Flag Stockholders: Reminder to Vote for Proposed Business Combination
16 Aug 23